Simon Cawley
Vice President of R&D in Clinical Next-Generation Sequencing at Thermo Fisher Scientific
ArticleDesigning targeted assays for clinical success from the start
Why do some targeted assays move smoothly from discovery to clinical practice while others stall? The answer often lies in the earliest design decisions, where choices about samples, platforms and data determine what is possible later.